CN Stock MarketDetailed Quotes

Zhejiang Yatai Pharmaceutical (002370)

Watchlist
  • 6.05
  • -0.13-2.10%
Market Closed May 21 15:00 CST
4.51BMarket Cap44.49P/E (TTM)

Zhejiang Yatai Pharmaceutical (002370) Balance Sheet

All
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q9)Sep 30, 2025
(Q6)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
Assets
Current assets
Money funds
-24.50%586.46M
-16.82%618.72M
-14.70%587.81M
-8.91%625.18M
17.14%776.79M
3.24%743.85M
-2.32%689.1M
-3.45%686.35M
-10.27%663.14M
-4.90%720.47M
Transactional financial assets
--30.06M
----
--30.08M
----
----
----
----
----
----
----
Notes receivable and accounts receivable
6.88%95.6M
-4.09%91.42M
29.09%103.55M
29.81%96.91M
23.62%89.45M
19.87%95.31M
-21.96%80.22M
-25.76%74.66M
-22.97%72.36M
-10.72%79.51M
-Notes receivable
----
--0
----
----
----
--0
----
----
----
----
-Accounts receivable
6.88%95.6M
-4.09%91.42M
29.09%103.55M
29.81%96.91M
23.62%89.45M
19.87%95.31M
-21.96%80.22M
-25.76%74.66M
-22.97%72.36M
-10.72%79.51M
Other receivables (including interest and dividends)
-95.86%614.47K
-96.72%530.19K
-90.01%3.31M
-97.59%719.56K
-4.49%14.83M
4.00%16.14M
97.59%33.14M
76.69%29.88M
5.23%15.52M
2.54%15.52M
-Accrued interest receivable
----
----
--2.73M
--165K
----
----
----
----
----
----
-Other receivable
----
-96.72%530.19K
----
-98.14%554.56K
----
4.00%16.14M
----
76.69%29.88M
----
2.54%15.52M
Advance payment
77.91%2.49M
30.24%4.04M
-33.16%1.35M
-16.72%1.21M
-55.87%1.4M
-26.97%3.1M
-60.17%2.01M
-30.28%1.46M
18.74%3.17M
19.06%4.24M
Inventories
25.84%100.94M
52.94%107.25M
-23.92%52.77M
-15.73%68.7M
-12.44%80.22M
-21.62%70.13M
-6.74%69.37M
0.73%81.52M
-1.82%91.61M
-6.02%89.47M
Receivable financing
-7.68%29.92M
288.78%63.63M
46.77%28.97M
34.53%35.42M
-17.12%32.41M
-49.31%16.37M
112.68%19.74M
120.63%26.33M
105.29%39.11M
21.41%32.29M
Other current assets
25.58%11.98M
23.63%12.69M
-25.80%8.14M
-24.27%8.82M
-22.55%9.54M
-24.91%10.26M
-24.01%10.97M
-22.32%11.65M
-21.02%12.32M
-22.65%13.67M
Total current assets
-14.59%858.06M
-5.96%898.27M
-9.79%815.98M
-8.21%836.96M
11.97%1B
-0.00%955.16M
-2.55%904.55M
-2.82%911.84M
-8.29%897.22M
-4.94%955.18M
Non Current assets
Other non-current financial assets
-1.20%36.31M
-1.23%38.01M
-5.43%36.69M
11.79%39.11M
1.07%36.75M
1.95%38.49M
-2.44%38.8M
-6.85%34.99M
-18.03%36.36M
-7.84%37.75M
Investment real estate
----
----
----
----
----
----
-94.75%619.66K
-94.75%628.42K
-94.76%637.18K
-94.76%645.94K
Fixed assets
----
-12.83%294.71M
----
-13.10%304.89M
----
-7.31%338.08M
----
-5.09%350.85M
----
-5.13%364.75M
Constru in process
----
-44.92%16.09K
----
-30.84%552.5K
----
-13.11%29.22K
----
91.23%798.89K
----
--33.63K
Intangible assets
-19.02%42.71M
-18.81%44M
-21.16%43.29M
-20.74%44.66M
-8.70%52.75M
-8.46%54.2M
-7.49%54.91M
-7.30%56.34M
-0.53%57.77M
3.47%59.21M
Development expenditure
-65.08%5.45M
-69.92%4.7M
20.72%16.46M
26.68%16.46M
24.37%15.62M
40.28%15.62M
0.03%13.64M
-4.67%13M
-28.68%12.56M
-43.26%11.13M
Long deferred expense
----
----
-88.82%28.08K
-81.36%56.16K
-57.14%150.66K
-13.61%200.88K
-7.83%251.1K
-3.52%301.32K
-82.64%351.54K
-90.78%232.52K
Other non current assets
----
----
----
----
----
----
----
----
----
92.27%436.33K
Total non current assets
-14.11%374.83M
-14.59%381.44M
-12.24%397.96M
-11.20%405.73M
-6.23%436.42M
-5.82%446.61M
-7.10%453.47M
-7.57%456.9M
-9.26%465.41M
-8.64%474.19M
Total assets
-14.45%1.23B
-8.71%1.28B
-10.61%1.21B
-9.21%1.24B
5.75%1.44B
-1.93%1.4B
-4.12%1.36B
-4.46%1.37B
-8.62%1.36B
-6.20%1.43B
Liabilities
Current liabilities
Short term loan
----
----
----
----
--30.03M
-39.96%30.06M
----
----
----
-0.00%50.06M
Notes payable and accounts payable
15.31%76.84M
127.17%103.97M
43.30%50.02M
56.31%69.06M
29.59%66.63M
-11.64%45.77M
-22.85%34.91M
-6.29%44.18M
-42.65%51.42M
-42.34%51.8M
-Notes payable
225.34%60.31M
--60.31M
--15.35M
--33.89M
--18.54M
----
----
----
----
-92.36%2.32M
-Accounts payable
-65.64%16.52M
-4.61%43.65M
-0.67%34.67M
-20.38%35.18M
-6.47%48.09M
-7.50%45.77M
-0.75%34.91M
12.16%44.18M
-13.26%51.42M
-16.79%49.48M
Contract liabilities
124.13%14.16M
560.29%14.75M
-9.25%2.14M
-8.68%2.19M
-12.84%6.32M
-71.71%2.23M
-8.95%2.36M
-11.91%2.4M
243.17%7.25M
-41.28%7.89M
Advance receipts
----
----
----
----
----
----
-93.95%6.88K
-92.09%27.52K
-93.01%48.17K
-93.32%68.81K
Salaries payable
-3.42%6.19M
10.65%13.13M
-10.88%7.6M
-19.94%6.79M
-21.96%6.41M
1.20%11.87M
20.61%8.53M
14.34%8.49M
11.05%8.22M
-2.96%11.73M
Taxs payable
63.40%1.63M
-4.17%5.15M
10.67%1.97M
-15.81%3.32M
-25.50%998.57K
-1.65%5.37M
-23.03%1.78M
-17.34%3.94M
-65.66%1.34M
-49.58%5.46M
Other payable (including interest and dividends)
-83.89%7.87M
-30.43%13.33M
-44.85%17.46M
-41.05%18.06M
51.45%48.88M
-43.28%19.15M
-12.55%31.65M
-24.06%30.64M
-16.07%32.28M
-18.93%33.77M
-Other payable
----
-30.43%13.33M
----
-41.05%18.06M
----
-43.28%19.15M
----
-24.06%30.64M
----
-18.93%33.77M
Non current liabilities due within one year
----
----
----
--0
--270.46M
--301.7M
--606.59M
--645.56M
----
----
Other current liabilities
124.13%1.84M
560.29%1.92M
-9.25%277.94K
-8.68%284.46K
-12.84%821.03K
-71.71%290.33K
-8.95%306.26K
-11.91%311.48K
243.17%941.99K
-41.28%1.03M
Total current liabilities
-74.79%108.53M
-63.44%152.24M
-88.42%79.46M
-86.44%99.72M
324.23%430.55M
157.37%416.44M
376.77%686.13M
380.23%735.56M
-47.76%101.49M
-27.24%161.8M
Current liabilities
Bonds payable
----
----
----
--0
----
----
----
----
-29.13%636.53M
-28.95%639.48M
Estimate liabilities
----
----
-84.13%6.04M
-84.13%6.04M
-87.03%4.93M
-87.03%4.93M
0.00%38.04M
0.00%38.04M
-57.65%38.04M
-57.65%38.04M
Deferred tax liabilities
2.20%3.73M
3.23%3.98M
0.40%3.78M
25.13%4M
7.15%3.65M
6.80%3.86M
-2.83%3.77M
-4.58%3.2M
-11.70%3.4M
1.64%3.61M
Long term deferred income
-27.91%2.93M
-26.37%3.21M
-25.02%3.49M
-23.84%3.78M
-22.79%4.06M
-21.64%4.36M
-20.74%4.66M
-19.93%4.96M
-19.21%5.26M
-18.47%5.56M
Total non current liabilities
-47.36%6.65M
-45.31%7.19M
-71.35%13.32M
-70.10%13.82M
-98.15%12.64M
-98.08%13.15M
-94.59%46.47M
-95.18%46.2M
-31.56%683.24M
-31.35%686.7M
Total liabilities
-74.01%115.18M
-62.89%159.43M
-87.34%92.77M
-85.48%113.53M
-43.52%443.19M
-49.37%429.59M
-26.97%732.6M
-29.68%781.76M
-34.20%784.73M
-30.60%848.5M
Shareholders equity
Paid-in capital
0.82%745.67M
2.34%745.67M
19.26%745.67M
22.41%745.67M
21.41%739.63M
19.60%728.59M
10.77%625.24M
13.51%609.18M
13.51%609.18M
13.51%609.17M
Other equity instruments
----
----
----
----
-59.59%56.32M
-54.55%63.35M
-27.99%129.16M
-31.73%139.39M
-31.73%139.39M
-31.73%139.4M
Capital reserve funds
3.54%2.01B
5.14%2.01B
22.60%2.01B
25.79%2.01B
21.49%1.94B
19.64%1.91B
15.35%1.64B
21.66%1.59B
21.66%1.59B
21.66%1.59B
Surplus reserve funds
0.00%60.56M
0.00%60.56M
0.00%60.56M
0.00%60.56M
0.00%60.56M
0.00%60.56M
0.00%60.56M
0.00%60.56M
0.00%60.56M
0.00%60.56M
Retained profit
5.66%-1.69B
5.39%-1.69B
7.39%-1.69B
7.38%-1.68B
1.61%-1.8B
1.88%-1.79B
-0.92%-1.82B
-1.46%-1.82B
-0.67%-1.82B
-0.66%-1.82B
Other composite income
----
----
----
----
----
----
----
----
0.00%-598.38K
0.00%-598.38K
Shareholders equity without minority interests
12.01%1.12B
15.23%1.12B
79.27%1.12B
92.37%1.13B
72.67%997.86M
67.37%972.18M
51.39%625.43M
82.87%586.98M
93.54%577.91M
92.81%580.87M
Total shareholder equity
12.01%1.12B
15.23%1.12B
79.27%1.12B
92.37%1.13B
72.67%997.86M
67.37%972.18M
51.39%625.43M
82.87%586.98M
93.54%577.91M
92.81%580.87M
Total liabilityies and equity
-14.45%1.23B
-8.71%1.28B
-10.61%1.21B
-9.21%1.24B
5.75%1.44B
-1.93%1.4B
-4.12%1.36B
-4.46%1.37B
-8.62%1.36B
-6.20%1.43B
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
Zhengdan Zhiyuan (Shenzhen) Certified Public Accountants Firm (Special General Partnership)
--
--
--
Zhongxing Cai Guanghua Certified Public Accountants (Special General Partnership)
--
--
--
Zhongxing Cai Guanghua Certified Public Accountants (Special General Partnership)
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q9)Sep 30, 2025(Q6)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023
Assets
Current assets
Money funds -24.50%586.46M-16.82%618.72M-14.70%587.81M-8.91%625.18M17.14%776.79M3.24%743.85M-2.32%689.1M-3.45%686.35M-10.27%663.14M-4.90%720.47M
Transactional financial assets --30.06M------30.08M----------------------------
Notes receivable and accounts receivable 6.88%95.6M-4.09%91.42M29.09%103.55M29.81%96.91M23.62%89.45M19.87%95.31M-21.96%80.22M-25.76%74.66M-22.97%72.36M-10.72%79.51M
-Notes receivable ------0--------------0----------------
-Accounts receivable 6.88%95.6M-4.09%91.42M29.09%103.55M29.81%96.91M23.62%89.45M19.87%95.31M-21.96%80.22M-25.76%74.66M-22.97%72.36M-10.72%79.51M
Other receivables (including interest and dividends) -95.86%614.47K-96.72%530.19K-90.01%3.31M-97.59%719.56K-4.49%14.83M4.00%16.14M97.59%33.14M76.69%29.88M5.23%15.52M2.54%15.52M
-Accrued interest receivable ----------2.73M--165K------------------------
-Other receivable -----96.72%530.19K-----98.14%554.56K----4.00%16.14M----76.69%29.88M----2.54%15.52M
Advance payment 77.91%2.49M30.24%4.04M-33.16%1.35M-16.72%1.21M-55.87%1.4M-26.97%3.1M-60.17%2.01M-30.28%1.46M18.74%3.17M19.06%4.24M
Inventories 25.84%100.94M52.94%107.25M-23.92%52.77M-15.73%68.7M-12.44%80.22M-21.62%70.13M-6.74%69.37M0.73%81.52M-1.82%91.61M-6.02%89.47M
Receivable financing -7.68%29.92M288.78%63.63M46.77%28.97M34.53%35.42M-17.12%32.41M-49.31%16.37M112.68%19.74M120.63%26.33M105.29%39.11M21.41%32.29M
Other current assets 25.58%11.98M23.63%12.69M-25.80%8.14M-24.27%8.82M-22.55%9.54M-24.91%10.26M-24.01%10.97M-22.32%11.65M-21.02%12.32M-22.65%13.67M
Total current assets -14.59%858.06M-5.96%898.27M-9.79%815.98M-8.21%836.96M11.97%1B-0.00%955.16M-2.55%904.55M-2.82%911.84M-8.29%897.22M-4.94%955.18M
Non Current assets
Other non-current financial assets -1.20%36.31M-1.23%38.01M-5.43%36.69M11.79%39.11M1.07%36.75M1.95%38.49M-2.44%38.8M-6.85%34.99M-18.03%36.36M-7.84%37.75M
Investment real estate -------------------------94.75%619.66K-94.75%628.42K-94.76%637.18K-94.76%645.94K
Fixed assets -----12.83%294.71M-----13.10%304.89M-----7.31%338.08M-----5.09%350.85M-----5.13%364.75M
Constru in process -----44.92%16.09K-----30.84%552.5K-----13.11%29.22K----91.23%798.89K------33.63K
Intangible assets -19.02%42.71M-18.81%44M-21.16%43.29M-20.74%44.66M-8.70%52.75M-8.46%54.2M-7.49%54.91M-7.30%56.34M-0.53%57.77M3.47%59.21M
Development expenditure -65.08%5.45M-69.92%4.7M20.72%16.46M26.68%16.46M24.37%15.62M40.28%15.62M0.03%13.64M-4.67%13M-28.68%12.56M-43.26%11.13M
Long deferred expense ---------88.82%28.08K-81.36%56.16K-57.14%150.66K-13.61%200.88K-7.83%251.1K-3.52%301.32K-82.64%351.54K-90.78%232.52K
Other non current assets ------------------------------------92.27%436.33K
Total non current assets -14.11%374.83M-14.59%381.44M-12.24%397.96M-11.20%405.73M-6.23%436.42M-5.82%446.61M-7.10%453.47M-7.57%456.9M-9.26%465.41M-8.64%474.19M
Total assets -14.45%1.23B-8.71%1.28B-10.61%1.21B-9.21%1.24B5.75%1.44B-1.93%1.4B-4.12%1.36B-4.46%1.37B-8.62%1.36B-6.20%1.43B
Liabilities
Current liabilities
Short term loan ------------------30.03M-39.96%30.06M-------------0.00%50.06M
Notes payable and accounts payable 15.31%76.84M127.17%103.97M43.30%50.02M56.31%69.06M29.59%66.63M-11.64%45.77M-22.85%34.91M-6.29%44.18M-42.65%51.42M-42.34%51.8M
-Notes payable 225.34%60.31M--60.31M--15.35M--33.89M--18.54M-----------------92.36%2.32M
-Accounts payable -65.64%16.52M-4.61%43.65M-0.67%34.67M-20.38%35.18M-6.47%48.09M-7.50%45.77M-0.75%34.91M12.16%44.18M-13.26%51.42M-16.79%49.48M
Contract liabilities 124.13%14.16M560.29%14.75M-9.25%2.14M-8.68%2.19M-12.84%6.32M-71.71%2.23M-8.95%2.36M-11.91%2.4M243.17%7.25M-41.28%7.89M
Advance receipts -------------------------93.95%6.88K-92.09%27.52K-93.01%48.17K-93.32%68.81K
Salaries payable -3.42%6.19M10.65%13.13M-10.88%7.6M-19.94%6.79M-21.96%6.41M1.20%11.87M20.61%8.53M14.34%8.49M11.05%8.22M-2.96%11.73M
Taxs payable 63.40%1.63M-4.17%5.15M10.67%1.97M-15.81%3.32M-25.50%998.57K-1.65%5.37M-23.03%1.78M-17.34%3.94M-65.66%1.34M-49.58%5.46M
Other payable (including interest and dividends) -83.89%7.87M-30.43%13.33M-44.85%17.46M-41.05%18.06M51.45%48.88M-43.28%19.15M-12.55%31.65M-24.06%30.64M-16.07%32.28M-18.93%33.77M
-Other payable -----30.43%13.33M-----41.05%18.06M-----43.28%19.15M-----24.06%30.64M-----18.93%33.77M
Non current liabilities due within one year --------------0--270.46M--301.7M--606.59M--645.56M--------
Other current liabilities 124.13%1.84M560.29%1.92M-9.25%277.94K-8.68%284.46K-12.84%821.03K-71.71%290.33K-8.95%306.26K-11.91%311.48K243.17%941.99K-41.28%1.03M
Total current liabilities -74.79%108.53M-63.44%152.24M-88.42%79.46M-86.44%99.72M324.23%430.55M157.37%416.44M376.77%686.13M380.23%735.56M-47.76%101.49M-27.24%161.8M
Current liabilities
Bonds payable --------------0-----------------29.13%636.53M-28.95%639.48M
Estimate liabilities ---------84.13%6.04M-84.13%6.04M-87.03%4.93M-87.03%4.93M0.00%38.04M0.00%38.04M-57.65%38.04M-57.65%38.04M
Deferred tax liabilities 2.20%3.73M3.23%3.98M0.40%3.78M25.13%4M7.15%3.65M6.80%3.86M-2.83%3.77M-4.58%3.2M-11.70%3.4M1.64%3.61M
Long term deferred income -27.91%2.93M-26.37%3.21M-25.02%3.49M-23.84%3.78M-22.79%4.06M-21.64%4.36M-20.74%4.66M-19.93%4.96M-19.21%5.26M-18.47%5.56M
Total non current liabilities -47.36%6.65M-45.31%7.19M-71.35%13.32M-70.10%13.82M-98.15%12.64M-98.08%13.15M-94.59%46.47M-95.18%46.2M-31.56%683.24M-31.35%686.7M
Total liabilities -74.01%115.18M-62.89%159.43M-87.34%92.77M-85.48%113.53M-43.52%443.19M-49.37%429.59M-26.97%732.6M-29.68%781.76M-34.20%784.73M-30.60%848.5M
Shareholders equity
Paid-in capital 0.82%745.67M2.34%745.67M19.26%745.67M22.41%745.67M21.41%739.63M19.60%728.59M10.77%625.24M13.51%609.18M13.51%609.18M13.51%609.17M
Other equity instruments -----------------59.59%56.32M-54.55%63.35M-27.99%129.16M-31.73%139.39M-31.73%139.39M-31.73%139.4M
Capital reserve funds 3.54%2.01B5.14%2.01B22.60%2.01B25.79%2.01B21.49%1.94B19.64%1.91B15.35%1.64B21.66%1.59B21.66%1.59B21.66%1.59B
Surplus reserve funds 0.00%60.56M0.00%60.56M0.00%60.56M0.00%60.56M0.00%60.56M0.00%60.56M0.00%60.56M0.00%60.56M0.00%60.56M0.00%60.56M
Retained profit 5.66%-1.69B5.39%-1.69B7.39%-1.69B7.38%-1.68B1.61%-1.8B1.88%-1.79B-0.92%-1.82B-1.46%-1.82B-0.67%-1.82B-0.66%-1.82B
Other composite income --------------------------------0.00%-598.38K0.00%-598.38K
Shareholders equity without minority interests 12.01%1.12B15.23%1.12B79.27%1.12B92.37%1.13B72.67%997.86M67.37%972.18M51.39%625.43M82.87%586.98M93.54%577.91M92.81%580.87M
Total shareholder equity 12.01%1.12B15.23%1.12B79.27%1.12B92.37%1.13B72.67%997.86M67.37%972.18M51.39%625.43M82.87%586.98M93.54%577.91M92.81%580.87M
Total liabilityies and equity -14.45%1.23B-8.71%1.28B-10.61%1.21B-9.21%1.24B5.75%1.44B-1.93%1.4B-4.12%1.36B-4.46%1.37B-8.62%1.36B-6.20%1.43B
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --Zhengdan Zhiyuan (Shenzhen) Certified Public Accountants Firm (Special General Partnership)------Zhongxing Cai Guanghua Certified Public Accountants (Special General Partnership)------Zhongxing Cai Guanghua Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
According to Saudi sources, the United States and Iran will hold a new round of talks in Islamabad, the capital of Pakistan, after the end o Show More